Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.
The recent emergence of a novel coronavirus (SARS-CoV-2) in China has caused significant public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2. In this study, we present the crystal structure of the C-terminal domain of SARS-CoV-2 (SARS-CoV-2-CTD) spike (S) protein in complex with human ACE2 (hACE2), ... which reveals a hACE2-binding mode similar overall to that observed for SARS-CoV. However, atomic details at the binding interface demonstrate that key residue substitutions in SARS-CoV-2-CTD slightly strengthen the interaction and lead to higher affinity for receptor binding than SARS-RBD. Additionally, a panel of murine monoclonal antibodies (mAbs) and polyclonal antibodies (pAbs) against SARS-CoV-S1/receptor-binding domain (RBD) were unable to interact with the SARS-CoV-2 S protein, indicating notable differences in antigenicity between SARS-CoV and SARS-CoV-2. These findings shed light on the viral pathogenesis and provide important structural information regarding development of therapeutic countermeasures against the emerging virus.
Mesh Terms:
Amino Acid Sequence, Angiotensin-Converting Enzyme 2, Betacoronavirus, Epitopes, Humans, Models, Molecular, Peptidyl-Dipeptidase A, Phylogeny, Protein Domains, SARS-CoV-2, Sequence Alignment, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus, Virus Internalization
Amino Acid Sequence, Angiotensin-Converting Enzyme 2, Betacoronavirus, Epitopes, Humans, Models, Molecular, Peptidyl-Dipeptidase A, Phylogeny, Protein Domains, SARS-CoV-2, Sequence Alignment, Severe acute respiratory syndrome-related coronavirus, Spike Glycoprotein, Coronavirus, Virus Internalization
Cell
Date: May. 14, 2020
PubMed ID: 32275855
View in: Pubmed Google Scholar
Download Curated Data For This Publication
242945
Switch View:
- Interactions 4